State Of Wisconsin Investment Board Allovir, Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.15 - $3.64 $19,178 - $32,468	-8,920 Reduced 9.62%	83,829 $180,000
Q2 2023 Aug 14, 2023	SELL	$3.17 - $5.82 $174,936 - $321,176	-55,185 Reduced 37.3%	92,749 $315,000
Q1 2023 May 15, 2023	SELL	$3.94 - $7.05 $57,027 - $102,041	-14,474 Reduced 8.91%	147,934 $582,000
Q4 2022 Feb 14, 2023	SELL	$4.7 - $9.98 $145,460 - $308,871	-30,949 Reduced 16.01%	162,408 $833,000
Q3 2022 Nov 14, 2022	SELL	$4.13 - $8.79 $178,498 - $379,903	-43,220 Reduced 18.27%	193,357 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $465,453 - $1.01 Million	142,777 Added 152.21%	236,577 $923,000
Q1 2022 May 13, 2022	BUY	$6.75 - $13.52 $462,375 - $926,120	68,500 Added 270.75%	93,800 $633,000
Q4 2020 Feb 03, 2021	BUY	$23.94 - $46.81 $605,682 - $1.18 Million	25,300 New	25,300 $973,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $50.3M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.